These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11257397)

  • 1. Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents.
    Srivastava PK; Amato RJ
    Vaccine; 2001 Mar; 19(17-19):2590-7. PubMed ID: 11257397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens.
    Srivastava PK
    Methods; 1997 Jun; 12(2):165-71. PubMed ID: 9184380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock proteins: the fountainhead of innate and adaptive immune responses.
    Basu S; Srivastava PK
    Cell Stress Chaperones; 2000 Nov; 5(5):443-51. PubMed ID: 11189450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein vaccines: from bench to bedside.
    Binder RJ
    Int Rev Immunol; 2006; 25(5-6):353-75. PubMed ID: 17169780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat shock protein-based novel immunotherapies.
    Srivastava PK
    Drug News Perspect; 2000 Nov; 13(9):517-22. PubMed ID: 12879122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune activity of heat shock protein gp96 and its application in active immunotherapy for tumor and infectious diseases].
    Xu Y; Wang S; Zhang X; Meng S
    Sheng Wu Gong Cheng Xue Bao; 2012 Mar; 28(3):261-6. PubMed ID: 22712385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to stress proteins: applications to infectious disease and cancer.
    Mizzen L
    Biotherapy; 1998; 10(3):173-89. PubMed ID: 9559972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous heat-shock protein vaccines.
    Colaco C
    Hum Vaccin Immunother; 2013 Feb; 9(2):275-6. PubMed ID: 23291947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat-shock protein-based vaccines for cancer and infectious disease.
    Binder RJ
    Expert Rev Vaccines; 2008 Apr; 7(3):383-93. PubMed ID: 18393608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat-shock protein-peptide complex-96 for the treatment of cancer.
    Amato RJ
    Expert Opin Biol Ther; 2007 Aug; 7(8):1267-73. PubMed ID: 17696824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock proteins as vaccine adjuvants in infections and cancer.
    Segal BH; Wang XY; Dennis CG; Youn R; Repasky EA; Manjili MH; Subjeck JR
    Drug Discov Today; 2006 Jun; 11(11-12):534-40. PubMed ID: 16713905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer vaccines: an update.
    Hipp JD; Hipp JA; Lyday BW; Minev BR
    In Vivo; 2000; 14(5):571-85. PubMed ID: 11125541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heat shock proteins, immune competence and vaccination].
    Milani V; Endres M; Kuppner MC; Issels RD; Noessner E
    Dtsch Med Wochenschr; 2004 Jan; 129(1-2):31-5. PubMed ID: 14703579
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges in the development of an autologous heat shock protein based anti-tumor vaccine.
    Reitsma DJ; Combest AJ
    Hum Vaccin Immunother; 2012 Aug; 8(8):1152-5. PubMed ID: 22854658
    [No Abstract]   [Full Text] [Related]  

  • 15. Heat shock proteins and cancer immunotherapy.
    Wang XY; Kaneko Y; Repasky E; Subjeck JR
    Immunol Invest; 2000 May; 29(2):131-7. PubMed ID: 10854181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of cancer using heat shock proteins.
    Manjili MH; Wang XY; Park J; Facciponte JG; Repasky EA; Subjeck JR
    Front Biosci; 2002 Jan; 7():d43-52. PubMed ID: 11779704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular chaperones and cancer immunotherapy.
    Wang XY; Facciponte JG; Subjeck JR
    Handb Exp Pharmacol; 2006; (172):305-29. PubMed ID: 16610365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvants for vaccines, a quest.
    Audibert F
    Int Immunopharmacol; 2003 Aug; 3(8):1187-93. PubMed ID: 12860174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I interferons as vaccine adjuvants against infectious diseases and cancer.
    Bracci L; La Sorsa V; Belardelli F; Proietti E
    Expert Rev Vaccines; 2008 Apr; 7(3):373-81. PubMed ID: 18393607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses.
    Srivastava P
    Annu Rev Immunol; 2002; 20():395-425. PubMed ID: 11861608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.